Philadelphia chromosome positive chronic myeloid leukemia with 5q deletion at diagnosis

Ahmed Maseh Haidary, Zeeshan Ansar Ahmed, Jamshid Abdul-Ghafar, Soma Rahmani, Sarah Noor, Farahnaz Erfani, Maryam Ahmad, Naeem Lakanwall, Haider Ali Malakzai, Abdul Sami Ibrahimkhil, Esmatullah Esmat, Mujtaba Haidari, Nimattullah Yousufzai, Samuel Sharif, Abdul Hadi Saqib

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Background: Although, molecular genetic analyses became more and more important to guide therapy decisions in leukemia, banding cytogenetic analysis has retained its vital role in diagnosis and monitoring of chronic myeloid leukemia (CML), by quick and easy enabling identification of pathognomonic Philadelphia chromosome (Ph). Case presentation: A 45 year old female presented with characteristic hematological features of CML in chronic phase; cytogenetic studies revealed the presence of the typical Ph and a deletion of almost entire long arm of a chromosome 5. Conclusion: 5q deletions have rarely been reported in CML. Those seen yet were either associated with tyrosine kinase inhibitor therapy or detected post allogeneic stem cell transplantation. To our knowledge, this is the first case of Ph positive CML accompanied by a 5q deletion.

Original languageEnglish
Article number16
JournalMolecular Cytogenetics
Volume14
Issue number1
DOIs
Publication statusPublished - Dec 2021
Externally publishedYes

Keywords

  • 5q deletion
  • Chronic myelogenous leukemia (CML)
  • Philadelphia chromosome (Ph)

Fingerprint

Dive into the research topics of 'Philadelphia chromosome positive chronic myeloid leukemia with 5q deletion at diagnosis'. Together they form a unique fingerprint.

Cite this